Optical Coherence Tomography Market: Regulatory Approvals, Clinical Adoption Trends & Growth Outlook

According to IMARC Group's latest research publication, The global optical coherence tomography market size was valued at USD 2.6 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 7.0 Billion by 2034, exhibiting a CAGR of 11.13% from 2026-2034.

How AI is Reshaping the Future of Optical Coherence Tomography Market

• Automated Diagnostic Accuracy and Disease Detection: AI-powered deep learning algorithms enable automated analysis of OCT images with exceptional precision, detecting subtle patterns in retinal layers that may escape human observation.
• Enhanced Image Quality and Real-Time Processing: AI technology overcomes technical restrictions in OCT imaging through dramatic improvements in image resolution, noise reduction, and real-time data processing capabilities.

• Predictive Analytics and Disease Progression Monitoring: AI-driven OCT systems extract complex biomarkers and patterns from imaging data that remain imperceptible to conventional analysis, enabling early intervention before severe visual impairments develop.

Stay Ahead with Updated 2026 Market Intelligence

Optical Coherence Tomography Industry Overview:

The Advanced Research Projects Agency for Health launched a USD 20 million initiative to develop compact, affordable OCT devices, enhancing early detection capabilities and potentially preventing severe visual impairments across underserved populations. This federal investment accelerates preventive screening and strengthens market expansion beyond traditional ophthalmology practices into primary care integration.

Optical Coherence Tomography Market Trends & Drivers:

The explosive growth of diabetic retinopathy and age-related eye conditions is driving unprecedented demand for advanced OCT diagnostic capabilities worldwide. An estimated 9.6 million Americans currently live with diabetic retinopathy, with prevalence rates reaching 26.4% among diabetic patients, representing more than a doubling since previous estimates.

Rapid technological advancement in swept-source and spectral-domain OCT systems is reshaping competitive dynamics and expanding clinical applications beyond traditional ophthalmology. Heidelberg Engineering's FDA-approved SPECTRALIS OCTA module with SHIFT technology reduces acquisition times by 50% with preset speeds of 125,000 Hz, dramatically improving workflow efficiency while maintaining exceptional image quality.

Healthcare infrastructure investments and favorable regulatory environments are accelerating OCT adoption across North America, Europe, and Asia-Pacific regions through distinct growth mechanisms. North America maintains approximately 40% market share supported by Medicare reimbursement for OCT angiography, despite physician fee schedule cuts reducing the conversion factor to USD 32.35 while new CPT codes for OCT-angiography partially offset margin pressures.

Leading Companies Operating in the Global Optical Coherence Tomography Industry:

• Abbott Laboratories
• Agfa-Gevaert N.V.
• Agiltron Inc.
• Carl Zeiss AG
• Haag-Streit Group

• Heidelberg Engineering Inc.
• Leica Microsystems GmbH (Danaher Corporation)
• Novacam Technologies Inc.
• OPTOPOL Technology Sp. z o.o.
• Terumo Corporation
• Thorlabs Inc.
• Topcon Corporation

Optical Coherence Tomography Market Report Segmentation:

By Type:

• Handheld OCT Devices
• Tabletop OCT Devices
• Others

Handheld OCT devices represent the largest segment, as they offer superior portability and point-of-care accessibility for diverse clinical settings.

By Technology:

• Time Domain OCT (TDOCT)
• Frequency Domain OCT (FD-OCT)

Frequency Domain OCT holds the largest market share owing to faster imaging speeds, higher resolution capabilities, and improved signal-to-noise ratios compared to time-domain systems.

By Application:

• Dermatology
• Ophthalmology
• Cardiovascular
• Oncology
• Others

Ophthalmology exhibits clear dominance in the market due to established clinical protocols, widespread insurance coverage, and extensive validation for retinal disease diagnosis and monitoring.

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America exhibits clear dominance in the optical coherence tomography market due to advanced healthcare infrastructure, favorable reimbursement policies, and high prevalence of ophthalmic disorders.

Recent News and Developments in Optical Coherence Tomography Market

• November 2024: The NHS in England unveiled its plan to widely implement optical coherence tomography scans to bring technology closer to patients' homes and potentially reduce hospital visits for eye care by having all eye care services offering OCT by October 2025.
• October 2024: Siloton, a Bristol-based health tech start-up, secured £860,000 (USD 1.1 million) in funding for further development of its Akepa optical coherence tomography (OCT) chip technology aimed at combating age-related macular degeneration, the UK's leading cause of sight loss.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.